Cargando…
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented effort toward the development of an effective and safe vaccine. Aided by extensive research efforts into characterizing and developing countermeasures towards prior coronavirus ep...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733686/ https://www.ncbi.nlm.nih.gov/pubmed/33316346 http://dx.doi.org/10.1016/j.addr.2020.12.006 |